No Data
Ymir Link, TDSSE and others.
Acquired a part of Stocks in Boston Medical Sciences, which is engaged in the development and clinical deployment of the non-invasive colorectal cancer screening AI system <3070>. A basic agreement has been concluded regarding the acquisition of Stocks in Gold Star, which handles the export and wholesale of jelly beans and other groceries, and the establishment of a subsidiary <3542>. VEGA has revised its forecast downward, with this period's operating profit outlook at 0.9 billion yen, down from 1.2 billion yen. Shareholder benefits have been determined <3624>.
Key points of interest for PTS on the 31st = Kindan, Scroll, Konami Group, ETC.
▽ Kindeng <1944.T>, revised upward its consolidated financial estimates and dividends estimates for the fiscal year ending March 2025, and also announced the acquisition and cancellation of its own shares. ▽ Fuji Japan <2114.T>, revised upward its consolidated financial estimates and dividends estimates for the fiscal year ending March 2025. ▽ Nijigaki <5603.T>, revised upward its consolidated financial estimates and dividends estimates for the fiscal year ending March 2025. ▽ Max <6454.T>, revised upward its consolidated financial estimates and dividends estimates for the fiscal year ending March 2025. ▽ Scroll <8005.T>, revised upward its consolidated financial estimates and dividends estimates for the fiscal year ending March 2025.
Japan Tissue Engineering Co., Ltd. Reports Third Quarter Financial Results and Adjusted Forecast
Japan Tissue Engineering 9-Mos Parent Loss Y350.00M Vs Loss Y53.00M
Japan Tissue Engineering Sees Parent FY Loss Y223.00M
Japan Tissue Engineering: Summary of financial results for the 3rd quarter of the fiscal year ending March 31, 2025 [Japanese GAAP] (unconsolidated)
